The underpinning narrative is this: The industry is very open to conveying information in the clearest, most easily understood format. That's accepted across the industry.
What is challenged is that we're not embracing modern labelling solutions. You mentioned a few. There are others we can uncover. The lack of proper consultation with industry didn't allow any of those to be raised appropriately. Proper patient groups who have interests in this field weren't engaged in a meaningful way.
That's where we've landed. It's a 1980 solution to a 2020 problem.